Mechanisms of Azole Potentiation: Insights from Drug Repurposing Approaches

Principles of early drug discovery

Hughes, J., Rees, S., Kalindjian, S., & Philpott, K. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01127.x · Cited by 2,859 · see citing works

Bisphosphonates: Mechanism of action and role in clinical practice

Drake, M. T., Clarke, B. L., & Khosla, S. (2008) · Mayo Clinic Proceedings · doi:10.4065/83.9.1032 · Cited by 1,644 · see citing works

The HSP90 chaperone machinery

Schopf, F. H., Biebl, M. M., & Buchner, J. (2017) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.20 · Cited by 1,540 · see citing works

Candida species: current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options

Sardi, J. C. O., Scorzoni, L., Bernardi, T., Fusco-Almeida, A. M., & Mendes Giannini, M. J. S. (2013) · Journal of Medical Microbiology · doi:10.1099/jmm.0.045054-0 · Cited by 1,184 · see citing works

Structure and mechanism of the Hsp90 molecular chaperone machinery

Pearl, L. H., & Prodromou, C. (2006) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.75.103004.142738 · Cited by 1,103 · see citing works

Endoplasmic reticulum stress: molecular mechanism and therapeutic targets

Chen, X., Shi, C., He, M., Xiong, S., & Xia, X. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01570-w · Cited by 1,072 · see citing works

Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters

Sanglard, D., Kuchler, K., Ischer, F., Pagani, J. L., Monod, M., & Bille, J. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.11.2378 · Cited by 815 · see citing works

Flavonoid Bioavailability and Attempts for Bioavailability Enhancement

Thilakarathna, S. H., & Rupasinghe, H. P. V. (2013) · Nutrients · doi:10.3390/nu5093367 · Cited by 809 · see citing works

Statin-Associated Side Effects

Thompson, P. D., Panza, G. A., Zaleski, A. L., & Taylor, B. A. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.02.071 · Cited by 756 · see citing works

Resistance of Candida to azoles and echinocandins worldwide

Pristov, K. E., & Ghannoum, M. A. (2019) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2019.03.028 · Cited by 706 · see citing works

Hsp90 Potentiates the Rapid Evolution of New Traits: Drug Resistance in Diverse Fungi

Cowen, L. E., & Lindquist, S. (2005) · Science · doi:10.1126/science.1118370 · Cited by 698 · see citing works

Drug resistance and tolerance in fungi.

Berman, J., & Krysan, D. J. (2020) · Nature Reviews Microbiology · doi:10.1038/s41579-019-0322-2 · Cited by 654 · see citing works

Road to Ruin: Targeting Proteins for Degradation in the Endoplasmic Reticulum

Smith, M. H., Ploegh, H. L., & Weissman, J. S. (2011) · Science · doi:10.1126/science.1209235 · Cited by 648 · see citing works

Development and regulation of single- and multi-species Candida albicans biofilms

Lohse, M. B., Gulati, M., Johnson, A. D., & Nobile, C. J. (2018) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.107 · Cited by 643 · see citing works

Monoamine oxidase inactivation: from pathophysiology to therapeutics

Bortolato, M., Chen, K., & Shih, J. C. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.06.002 · Cited by 634 · see citing works

Review of Drug Repositioning Approaches and Resources

Xue, H., Li, J., Xie, H., & Wang, Y. (2018) · International Journal of Biological Sciences · doi:10.7150/ijbs.24612 · Cited by 613 · see citing works

Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterization of CDR2, a new multidrug ABC transporter gene

Sanglard, D., Ischer, F., Monod, M., & Bille, J. (1997) · Microbiology · doi:10.1099/00221287-143-2-405 · Cited by 587 · see citing works

Regulation of Ergosterol Biosynthesis in Saccharomyces cerevisiae

Jordá, T., & Puig, S. (2020) · Genes · doi:10.3390/genes11070795 · Cited by 489 · see citing works

Natural Berberine-Based Chinese Herb Medicine Assembled Nanostructures with Modified Antibacterial Application

Li, T., Wang, P., Guo, W., Huang, X., Tian, X., Wu, G., Xu, B., Li, F., Yan, C., Liang, X., et al. (2019) · ACS Nano · doi:10.1021/acsnano.9b01346 · Cited by 465 · see citing works

Architecture of the dynamic fungal cell wall

Gow, N. A. R., & Lenardon, M. D. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00796-9 · Cited by 447 · see citing works

A Phenotypic Profile of the Candida albicans Regulatory Network

Homann, O. R., Dea, J., Noble, S. M., & Johnson, A. D. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000783 · Cited by 444 · see citing works

Structure, Function and Regulation of the Hsp90 Machinery

Büchner, J., & Li, J. (2013) · Biomedical Journal · doi:10.4103/2319-4170.113230 · Cited by 421 · see citing works

Harnessing Hsp90 function as a powerful, broadly effective therapeutic strategy for fungal infectious disease

Cowen, L. E., Singh, S. D., Köhler, J. R., Collins, C., Zaas, A. K., Schell, W. A., Aziz, H., Mylonakis, E., Perfect, J. R., Whitesell, L., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813394106 · Cited by 413 · see citing works

Global Warming Will Bring New Fungal Diseases for Mammals

Garcia-Solache, M. A., & Casadevall, A. (2010) · mBio · doi:10.1128/mbio.00061-10 · Cited by 370 · see citing works

Hsp90 Governs Echinocandin Resistance in the Pathogenic Yeast Candida albicans via Calcineurin

Singh, S. D., Robbins, N., Zaas, A. K., Schell, W. A., Perfect, J. R., & Cowen, L. E. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000532 · Cited by 362 · see citing works

PKC Signaling Regulates Drug Resistance of the Fungal Pathogen Candida albicans via Circuitry Comprised of Mkc1, Calcineurin, and Hsp90

LaFayette, S. L., Collins, C., Zaas, A. K., Schell, W. A., Betancourt-Quiroz, M., Gunatilaka, A. A. L., Perfect, J. R., & Cowen, L. E. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001069 · Cited by 329 · see citing works

The rapid emergence of antifungal-resistant human-pathogenic fungi

Lockhart, S. R., Chowdhary, A., & Gold, J. A. W. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-023-00960-9 · Cited by 315 · see citing works

History of the development of antifungal azoles: A review on structures, SAR, and mechanism of action

Shafiei, M., Peyton, L., Hashemzadeh, M., & Foroumadi, A. (2020) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2020.104240 · Cited by 295 · see citing works

Hsp90 Governs Dispersion and Drug Resistance of Fungal Biofilms

Robbins, N., Uppuluri, P., Nett, J., Rajendran, R., Ramage, G., Lopez-Ribot, J. L., Andes, D., & Cowen, L. E. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002257 · Cited by 291 · see citing works

A Candida Biofilm-Induced Pathway for Matrix Glucan Delivery: Implications for Drug Resistance

Taff, H. T., Nett, J. E., Zarnowski, R., Ross, K. M., Sanchez, H., Cain, M. T., Hamaker, J., Mitchell, A. P., & Andes, D. R. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002848 · Cited by 291 · see citing works

Drug repurposing: far beyond new targets for old drugs

Oprea, T. I., & Mestres, J. (2012) · The AAPS Journal · doi:10.1208/s12248-012-9390-1 · Cited by 285 · see citing works

Ergosterol Biosynthesis Inhibitors Become Fungicidal when Combined with Calcineurin Inhibitors against <i>Candida albicans</i> , <i>Candida glabrata</i> , and <i>Candida krusei</i>

Onyewu, C., Blankenship, J. R., Del Poeta, M., & Heitman, J. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.3.956-964.2003 · Cited by 282 · see citing works

Antifungal tolerance is a subpopulation effect distinct from resistance and is associated with persistent candidemia

Rosenberg, A., Ene, I. V., Bibi, M., Zakin, S., Segal, E. S., Ziv, N., Dahan, A. M., Colombo, A. L., Bennett, R. J., & Berman, J. (2018) · Nature Communications · doi:10.1038/s41467-018-04926-x · Cited by 270 · see citing works

Candida albicans biofilm growth and dispersal: contributions to pathogenesis

Wall, G., Montelongo-Jauregui, D., Vidal Bonifacio, B., Lopez-Ribot, J. L., & Uppuluri, P. (2019) · Current Opinion in Microbiology · doi:10.1016/j.mib.2019.04.001 · Cited by 263 · see citing works

Chalcone derivatives and their antibacterial activities: Current development

Xu, M., Wu, P., Shen, F., Ji, J., & Rakesh, K. P. (2019) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2019.103133 · Cited by 260 · see citing works

Carvacrol—A Natural Phenolic Compound with Antimicrobial Properties

Mączka, W. K., Twardawska, M., Grabarczyk, M., & Wińska, K. (2023) · Antibiotics · doi:10.3390/antibiotics12050824 · Cited by 260 · see citing works

Worldwide emergence of fluconazole-resistant Candida parapsilosis: current framework and future research roadmap

Daneshnia, F., de Almeida Júnior, J. N., Ilkit, M., Lombardi, L., Perry, A. M., Gao, M., Nobile, C. J., Egger, M., Perlin, D. S., Zhai, B., et al. (2023) · The Lancet Microbe · doi:10.1016/s2666-5247(23)00067-8 · Cited by 257 · see citing works

In Vitro Drug Interaction Modeling of Combinations of Azoles with Terbinafine against Clinical Scedosporium prolificans Isolates

Meletiadis, J., Mouton, J. W., Meis, J. F. G. M., & Verweij, P. E. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.1.106-117.2003 · Cited by 252 · see citing works

Genetic Basis of<i>Candida</i>Biofilm Resistance Due to Drug‐Sequestering Matrix Glucan

Nett, J. E., Sanchez, H., Cain, M. T., & Andes, D. R. (2010) · The Journal of Infectious Diseases · doi:10.1086/651200 · Cited by 250 · see citing works

Understanding Echinocandin Resistance in the Emerging Pathogen Candida auris

Kordalewska, M., Lee, A., Park, S., Berrio, I., Chowdhary, A., Zhao, Y., & Perlin, D. S. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00238-18 · Cited by 247 · see citing works

Tetrandrine – A molecule of wide bioactivity

Bhagya, N., & Chandrashekar, K. R. (2016) · Phytochemistry · doi:10.1016/j.phytochem.2016.02.005 · Cited by 245 · see citing works

Portrait of Candida albicans Adherence Regulators

Finkel, J. S., Xu, W., Huang, D., Hill, E. M., Desai, J. V., Woolford, C. A., Nett, J. E., Taff, H., Norice, C. T., Andes, D. R., et al. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002525 · Cited by 228 · see citing works

Synergistic Effect of Calcineurin Inhibitors and Fluconazole against <i>Candida albicans</i> Biofilms

Uppuluri, P., Nett, J., Heitman, J., & Andes, D. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01397-07 · Cited by 228 · see citing works

Biological Activity of Berberine—A Summary Update

Och, A., Podgórski, R., & Nowak, R. (2020) · Toxins · doi:10.3390/toxins12110713 · Cited by 223 · see citing works

Monoamine Oxidase A–Mediated Enhanced Catabolism of Norepinephrine Contributes to Adverse Remodeling and Pump Failure in Hearts With Pressure Overload

Kaludercic, N., Takimoto, E., Nagayama, T., Feng, N., Lai, E. W., Bedja, D., Chen, K., Gabrielson, K. L., Blakely, R., Shih, J. C., et al. (2009) · Circulation Research · doi:10.1161/circresaha.109.198366 · Cited by 222 · see citing works

Carbohydrate MetabolismPreprint

Chandel, N. S. (2021) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a040568 · Cited by 216 · see citing works

Mechanistic Understanding of Candida albicans Biofilm Formation and Approaches for Its Inhibition

Atriwal, T., Azeem, K., Husain, F. M., Hussain, A., Khan, M. N., Alajmi, M. F., & Abid, M. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.638609 · Cited by 210 · see citing works

Role of Fks1p and Matrix Glucan in <i>Candida albicans</i> Biofilm Resistance to an Echinocandin, Pyrimidine, and Polyene

Nett, J. E., Crawford, K., Marchillo, K., & Andes, D. R. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00227-10 · Cited by 207 · see citing works

The Antidepressant Sertraline Provides a Promising Therapeutic Option for Neurotropic Cryptococcal Infections

Zhai, B., Wu, C., Wang, L., Sachs, M. S., & Lin, X. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00212-12 · Cited by 205 · see citing works

Efficacy of adjunctive sertraline for the treatment of HIV-associated cryptococcal meningitis: An open-label dose-ranging study

Rhein, J., Morawski, B. M., Hullsiek, K. H., Nabeta, H. W., Kiggundu, R., Tugume, L., Musubire, A., Akampurira, A., Smith, K. D., Alhadab, A., et al. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)00074-8 · Cited by 183 · see citing works

Old and New Approaches to Target the Hsp90 Chaperone

Sanchez, J., Carter, T. R., Cohen, M. S., & Blagg, B. S. J. (2020) · Current Cancer Drug Targets · doi:10.2174/1568009619666191202101330 · Cited by 183 · see citing works

Azole resistance mechanisms in Aspergillus: update and recent advances

Pérez‐Cantero, A., López‐Fernández, L., Guarro, J., & Capilla, J. (2019) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2019.09.011 · Cited by 175 · see citing works

Components of the Calcium-Calcineurin Signaling Pathway in Fungal Cells and Their Potential as Antifungal Targets

Liu, S., Hou, Y., Liu, W., Lu, C., Wang, W., & Sun, S. (2015) · Eukaryotic Cell · doi:10.1128/ec.00271-14 · Cited by 174 · see citing works

Structural and functional complexity of HSP90 in cellular homeostasis and disease

Chiosis, G., Digwal, C. S., Trepel, J., & Neckers, L. (2023) · Nature reviews. Molecular cell biology · doi:10.1038/s41580-023-00640-9 · Cited by 174 · see citing works

Candida glabrata: pathogenicity and resistance mechanisms for adaptation and survival

Hassan, Y., Chew, S. Y., & Than, L. T. L. (2021) · Journal of Fungi · doi:10.3390/jof7080667 · Cited by 170 · see citing works

Interface of Candida albicans Biofilm Matrix-Associated Drug Resistance and Cell Wall Integrity Regulation

Nett, J. E., Sanchez, H., Cain, M. T., Ross, K. M., & Andes, D. R. (2011) · Eukaryotic Cell · doi:10.1128/ec.05126-11 · Cited by 168 · see citing works

High-resolution chemical dissection of a model eukaryote reveals targets, pathways and gene functions

Hoepfner, D., Helliwell, S. B., Sadlish, H., Schuierer, S., Filipuzzi, I., Brachat, S., Bhullar, B., Plikat, U., Abraham, Y., Altorfer, M., et al. (2014) · Microbiological Research · doi:10.1016/j.micres.2013.11.004 · Cited by 166 · see citing works

Targeting Efflux Pumps to Overcome Antifungal Drug Resistance

Holmes, A. R., Cardno, T. S., Strouse, J. J., Ivnitski-Steele, I., Keniya, M. V., Lackovic, K., Monk, B. C., Sklar, L. A., & Cannon, R. D. (2016) · Future Medicinal Chemistry · doi:10.4155/fmc-2016-0050 · Cited by 156 · see citing works

A Comprehensive Review on the Benefits and Problems of Curcumin with Respect to Human Health

Liu, S., Liu, J., He, L., Liu, L., Cheng, B. H., Zhou, F., Cao, D., & He, Y. (2022) · Molecules · doi:10.3390/molecules27144400 · Cited by 145 · see citing works

Fungal Lanosterol 14α-demethylase: A target for next-generation antifungal design

Monk, B. C., Sagatova, A. A., Hosseini, P., Ruma, Y. N., Wilson, R. K., & Keniya, M. V. (2019) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2019.02.008 · Cited by 136 · see citing works

Hsp90 orchestrates stress response signaling governing fungal drug resistance

Cowen, L. E. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000471 · Cited by 130 · see citing works

Multidrug Transporters CaCdr1p and CaMdr1p of <i>Candida albicans</i> Display Different Lipid Specificities: both Ergosterol and Sphingolipids Are Essential for Targeting of CaCdr1p to Membrane Rafts

Pasrija, R., Panwar, S. L., & Prasad, R. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00861-07 · Cited by 125 · see citing works

Structural basis for species-selective targeting of Hsp90 in a pathogenic fungus

Whitesell, L., Robbins, N., Huang, D. S., McLellan, C. A., Shekhar-Guturja, T., LeBlanc, E. V., Nation, C. S., Hui, R., Hutchinson, A., Collins, C., et al. (2019) · Nature Communications · doi:10.1038/s41467-018-08248-w · Cited by 124 · see citing works

Utilising polyphenols for the clinical management of Candida albicans biofilms

Shahzad, M. A., Sherry, L., Rajendran, R., Edwards, C. A., Combet, E., & Ramage, G. (2014) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2014.05.017 · Cited by 116 · see citing works

ABC transporters Cdr1p, Cdr2p and Cdr3p of a human pathogen Candida albicans are general phospholipid translocators

Smriti, S., Krishnamurthy, S., Dixit, B. L., Gupta, C. M., Milewski, S., & Prasad, R. (2002) · Yeast · doi:10.1002/yea.818 · Cited by 113 · see citing works

Fluconazole plus Cyclosporine: a Fungicidal Combination Effective against Experimental Endocarditis Due to <i>Candida albicans</i>

Marchetti, O., Entenza, J. M., Sanglard, D., Bille, J., Glauser, M. P., & Moreillon, P. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.11.2932-2938.2000 · Cited by 113 · see citing works

In vitro antifungal activity of the flavonoid baicalein against Candida species

Serpa, R., de França, E. J. G., Furlaneto-Maia, L., Andrade, C. G. T. J., Diniz, A., & Furlaneto, M. C. (2012) · Journal of Medical Microbiology · doi:10.1099/jmm.0.047852-0 · Cited by 110 · see citing works

Antifungal activity and mechanism of action of Ou-gon (Scutellaria root extract) components against pathogenic fungi

Da, X., Nishiyama, Y., Tie, D., Hein, K. Z., Yamamoto, O., & Morita, E. (2019) · Scientific Reports · doi:10.1038/s41598-019-38916-w · Cited by 110 · see citing works

In Vitro Interaction of Terbinafine with Itraconazole against Clinical Isolates of Scedosporium prolificans

Meletiadis, J., Mouton, J. W., Rodrı́guez-Tudela, J. L., Meis, J. F. G. M., & Verweij, P. E. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.2.470-472.2000 · Cited by 109 · see citing works

The monoamine oxidase A inhibitor clorgyline is a broad-spectrum inhibitor of fungal ABC and MFS transporter efflux pump activities which reverses the azole resistance of Candida albicans and Candida glabrata clinical isolates

Holmes, A. R., Keniya, M. V., Ivnitski-Steele, I., Monk, B. C., Lamping, E., Sklar, L. A., & Cannon, R. D. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05706-11 · Cited by 106 · see citing works

In Vitro Interactions of Echinocandins with Triazoles against Multidrug-Resistant Candida auris

Fakhim, H., Chowdhary, A., Prakash, A., Vaezi, A., Dannaoui, É., Meis, J. F. G. M., & Badali, H. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01056-17 · Cited by 104 · see citing works

Molecular and genetic basis of azole antifungal resistance in the opportunistic pathogenic fungus<i>Candida albicans</i>

Nishimoto, A. T., Sharma, C., & Rogers, P. D. (2020) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz400 · Cited by 102 · see citing works

In vitro activity of baicalein against Candida albicans biofilms

Cao, Y., Dai, B., Wang, Y., Huang, S. H., Yong-gang, X., Cao, Y., Gao, P., Zhu, Z., & Jiang, Y. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2008.01.026 · Cited by 101 · see citing works

Candida Biofilms: An Update on Developmental Mechanisms and Therapeutic Challenges

de Barros, P. P., Rossoni, R. D., de Souza, C. M., Scorzoni, L., Fenley, J. D. C., & Junqueira, J. C. (2020) · Mycopathologia · doi:10.1007/s11046-020-00445-w · Cited by 99 · see citing works

Candidiasis: From cutaneous to systemic, new perspectives of potential targets and therapeutic strategies

Lu, H., Hong, T., Jiang, Y., Whiteway, M. S., & Zhang, S. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114960 · Cited by 96 · see citing works

Characterization of a Novel, Broad-Based Fungicidal Activity for the Antiarrhythmic Drug Amiodarone

Courchesne, W. E. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.300.1.195 · Cited by 94 · see citing works

Aspergillus fumigatus and pan-azole resistance: who should be concerned?

Wiederhold, N. P., & Verweij, P. E. (2020) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000662 · Cited by 93 · see citing works

p38α MAPK-mediated induction and interaction of FOXO3a and p53 contribute to the inhibited-growth and induced-apoptosis of human lung adenocarcinoma cells by berberine

Zheng, F., Tang, Q., Wu, J., Zhao, S., Liang, Z., Li, L., Wu, W., & Hann, S. S. (2014) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-33-36 · Cited by 90 · see citing works

Alizarin and Chrysazin Inhibit Biofilm and Hyphal Formation by Candida albicans

Manoharan, R. K., Lee, J., Kim, Y., & Lee, J. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00447 · Cited by 89 · see citing works

Promising Antifungal Targets Against Candida albicans Based on Ion Homeostasis

Li, Y., Sun, L., Lu, C., Gong, Y., Li, M., & Sun, S. (2018) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2018.00286 · Cited by 88 · see citing works

Synergistic Effect of Fluconazole and Calcium Channel Blockers against Resistant Candida albicans

Liu, S., Yue, L., Gu, W., Li, X., Zhang, L., & Sun, S. (2016) · PLOS ONE · doi:10.1371/journal.pone.0150859 · Cited by 87 · see citing works

Regulatory Role of Glycerol in Candida albicans Biofilm Formation

Desai, J. V., Bruno, V. M., Ganguly, S., Stamper, R. J., Mitchell, K. F., Solis, N. V., Hill, E. M., Xu, W., Filler, S. G., Andes, D. R., et al. (2013) · mBio · doi:10.1128/mbio.00637-12 · Cited by 86 · see citing works

Pharmacological review of isobavachalcone, a naturally occurring chalcone

Wang, M., Lin, L., Lu, J.-J., & Chen, X. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105483 · Cited by 85 · see citing works

The Anti-Adhesive Effect of Curcumin on Candida albicans Biofilms on Denture Materials

Alalwan, H. K. A., Rajendran, R., Lappin, D. F., Combet, E., Shahzad, M. A., Robertson, D. P., Nile, C. J., Williams, C., & Ramage, G. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00659 · Cited by 84 · see citing works

Functional Analysis of Ca IPT1 , a Sphingolipid Biosynthetic Gene Involved in Multidrug Resistance and Morphogenesis of Candida albicans

Prasad, T., Saini, P., Gaur, N. A., Vishwakarma, R. A., Khan, L. A., Haq, Q. M. R., & Prasad, R. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.8.3442-3452.2005 · Cited by 83 · see citing works

The Monoterpene Carvacrol Generates Endoplasmic Reticulum Stress in the Pathogenic Fungus Candida albicans

Chaillot, J., Tebbji, F., Remmal, A., Boone, C., Brown, G. W., Bellaoui, M., & Sellam, A. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00551-15 · Cited by 82 · see citing works

<i>Candida albicans</i>targets that potentially synergize with fluconazole

Lu, H., Shrivastava, M., Whiteway, M., & Jiang, Y. (2021) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2021.1884641 · Cited by 81 · see citing works

Sensitization of Candida albicans biofilms to fluconazole by terpenoids of plant origin

Doke, S. K., Raut, J. S., Dhawale, S. C., & Karuppayil, S. M. (2014) · The Journal of General and Applied Microbiology · doi:10.2323/jgam.60.163 · Cited by 79 · see citing works

Squalene epoxidase as a target for manipulation of squalene levels in the yeastSaccharomyces cerevisiae

Garaiová, M., Zambojová, V., Šimová, Z., Griač, P., & Hapala, I. (2013) · FEMS Yeast Research · doi:10.1111/1567-1364.12107 · Cited by 79 · see citing works

Berberine: A Plant-derived Alkaloid with Therapeutic Potential to Combat Alzheimer’s disease

Singh, A. K., Singh, S. K., Nandi, M. K., Mishra, G., Maurya, A., Rai, A., Rai, G. K., Awasthi, R., Sharma, B., & Kulkarni, G. T. (2019) · Central Nervous System Agents in Medicinal Chemistry · doi:10.2174/1871524919666190820160053 · Cited by 79 · see citing works

Environmental reservoirs of the drug-resistant pathogenic yeast Candida auris

Akinbobola, A., Kean, R., Hanifi, S. M. A., & Quilliam, R. S. (2023) · PLoS Pathogens · doi:10.1371/journal.ppat.1011268 · Cited by 78 · see citing works

In vitro activities of carvacrol, cinnamaldehyde and thymol against Candida biofilms

Miranda-Cadena, K., Marcos‐Arias, C., Mateo, E., Urízar, J. M. A., Quindós, G., & Eraso, E. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112218 · Cited by 77 · see citing works

Natural dimers of coumarin, chalcones, and resveratrol and the link between structure and pharmacology

Menezes, J. C. J. M. D. S., & Diederich, M. F. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.111637 · Cited by 74 · see citing works

In Vitro Synergism of Fluconazole and Baicalein against Clinical Isolates of Candida albicans Resistant to Fluconazole

Huang, S. H., Cao, Y., Dai, B. D., Sun, X. R., Zhu, Z., Cao, Y. B., Wang, Y., Gao, P. H., & Jiang, Y. Y. (2008) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.31.2234 · Cited by 73 · see citing works

Antifungal effects of statins

Tavakkoli, A., Johnston, T. P., & Sahebkar, A. (2020) · Pharmacology &amp; Therapeutics · doi:10.1016/j.pharmthera.2020.107483 · Cited by 73 · see citing works

Aminobisphosphonate-pretreated dendritic cells trigger successful Vγ9Vδ2 T cell amplification for immunotherapy in advanced cancer patients

Cabillic, F., Toutirais, O., Lavoué, V., Pintière, C. T. D. L., Daniel, P., Rioux-Leclercq, N. C., Turlin, B., Mönkkönen, H., Mönkkönen, J., Boudjéma, K., et al. (2010) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-010-0887-0 · Cited by 70 · see citing works

Mechanism of the Synergistic Effect of Amiodarone and Fluconazole in <i>Candida albicans</i>

Gamarra, S., Rocha, E. M. F., Zhang, Y.-Q., Park, S., Rao, R., & Perlin, D. S. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01728-09 · Cited by 70 · see citing works

Berberine mitigates high glucose-induced podocyte apoptosis by modulating autophagy via the mTOR/P70S6K/4EBP1 pathway

Li, C., Guan, X., Wang, R., Xie, Y., Zhou, H., Ni, W., & Tang, L. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117277 · Cited by 70 · see citing works

Update on the Benefits and Mechanisms of Action of the Bioactive Vegetal Alkaloid Berberine on Lipid Metabolism and Homeostasis

Wang, Y., & Zidichouski, J. A. (2018) · Cholesterol · doi:10.1155/2018/7173920 · Cited by 68 · see citing works

In Vitro Activities of Terbinafine in Combination with Fluconazole, Itraconazole, Voriconazole, and Posaconazole against Clinical Isolates of Candida glabrata with Decreased Susceptibility to Azoles

Perea, S. H., González, G. M., Fothergill, A. W., Sutton, D. A., & Rinaldi, M. G. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.5.1831-1833.2002 · Cited by 67 · see citing works

Activity of Polyphenolic Compounds against Candida glabrata

Salazar‐Aranda, R., Granados-Guzmán, G., Pérez-Meseguer, J., González, G. M., & de Torres, N. H. W. (2015) · Molecules · doi:10.3390/molecules201017903 · Cited by 65 · see citing works

Baicalein Protects Against Aspergillus fumigatus Keratitis by Reducing Fungal Load and Inhibiting TSLP-Induced Inflammatory Response

Zhu, Y., Peng, X., Zhang, Y., Lin, J., & Zhao, G. (2021) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.62.6.26 · Cited by 65 · see citing works

The Rpd3/Hda1 family of histone deacetylases regulates azole resistance in <i>Candida albicans</i>

Li, X., Cai, Q., Mei, H., Zhou, X., Shen, Y., Li, D., & Liu, W. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv070 · Cited by 64 · see citing works

A fourth gene from the Candida albicans CDR family of ABC transporters

Franz, R., Michel, S., & Morschhäuser, J. (1998) · Gene · doi:10.1016/s0378-1119(98)00412-0 · Cited by 64 · see citing works

Screening Repurposing Libraries for Identification of Drugs with Novel Antifungal Activity

Wall, G., & Lopez-Ribot, J. L. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00924-20 · Cited by 63 · see citing works

New antifungal strategies: Drug combination and co-delivery

Zhu, P., Li, Y., Guo, T., Liu, S., Tancer, R. J., Hu, C., Zhao, C., Xue, C., & Liao, G. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114874 · Cited by 63 · see citing works

The Hsp90 isoforms from S. cerevisiae differ in structure, function and client range

Girstmair, H., Tippel, F., López, A., Tych, K. M., Stein, F., Haberkant, P., Schmid, P. W. N., Helm, D., Rief, M., Sattler, M., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11518-w · Cited by 62 · see citing works

Cytotoxic and Proapoptotic Activity of Sanguinarine, Berberine, and Extracts of Chelidonium majus L. and Berberis thunbergii DC. toward Hematopoietic Cancer Cell Lines

Och, A., Zalewski, D. P., Komsta, Ł., Kołodziej, P., Kocki, J., & Bogucka‐Kocka, A. (2019) · Toxins · doi:10.3390/toxins11090485 · Cited by 61 · see citing works

In Vitro Activity of Terbinafine Combined with Caspofungin and Azoles against Pythium insidiosum

Cavalheiro, A. S., Maboni, G., Azevedo, M. I., Argenta, J. S., Pereira, D. I. B., Spader, T. B., Alves, S. H., & Santúrio, J. M. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01506-08 · Cited by 60 · see citing works

In vitro activity of verapamil alone and in combination with fluconazole or tunicamycin against Candida albicans biofilms

Yu, Q., Ding, X., Xu, N., Cheng, X., Qian, K., Zhang, B., Xing, L., & Li, M. (2012) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2012.10.009 · Cited by 60 · see citing works

Heat shock protein 90 (Hsp90)/Histone deacetylase (HDAC) dual inhibitors for the treatment of azoles-resistant Candida albicans

Li, C., Tu, J., Han, G., Liu, N., & Sheng, C. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113961 · Cited by 60 · see citing works

Synergistic Activities of Fluconazole and Voriconazole with Terbinafine against Four Candida Species Determined by Checkerboard, Time-Kill, and Etest Methods

Cantón, E., Pemán, J., Gobernado, M., Viudes, A., & Espinel‐Ingroff, A. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.4.1593-1596.2005 · Cited by 59 · see citing works

Multidrug transporters of Candida species in clinical azole resistance

Prasad, R., Nair, R., & Banerjee, A. (2019) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2019.103252 · Cited by 58 · see citing works

Candida albicans ENO1 null mutants exhibit altered drug susceptibility, hyphal formation, and virulence

Ko, H.-C., Hsiao, T.-Y., Chen, C., & Yang, Y.-L. (2013) · The Journal of Microbiology · doi:10.1007/s12275-013-2577-z · Cited by 56 · see citing works

In vitro susceptibility of dermatomycoses agents to six antifungal drugs and evaluation by fractional inhibitory concentration index of combined effects of amorolfine and itraconazole in dermatophytes

Tamura, T., Asahara, M., Yamamoto, M., Yamaura, M., MATSUMURA, M., Gotō, K., Rezaei‐Matehkolaei, A., Mirhendi, H., Makimura, M., & Makimura, K. (2013) · Microbiology and Immunology · doi:10.1111/1348-0421.12109 · Cited by 56 · see citing works

Repurposing approach identifies pitavastatin as a potent azole chemosensitizing agent effective against azole-resistant Candida species

Eldesouky, H. E., Salama, E. A., Li, X., Hazbun, T. R., Mayhoub, A. S., & Seleem, M. N. (2020) · Scientific Reports · doi:10.1038/s41598-020-64571-7 · Cited by 55 · see citing works

Plant Preparations and Compounds with Activities against Biofilms Formed by Candida spp.

Karpiński, T. M. M., Ożarowski, M., Seremak‐Mrozikiewicz, A., Wolski, H., & Adamczak, A. (2021) · Journal of Fungi · doi:10.3390/jof7050360 · Cited by 55 · see citing works

Time-Kill Assay and Etest Evaluation for Synergy with Polymyxin B and Fluconazole against Candida glabrata

Pankey, G. A., Ashcraft, D. S., Kahn, H. P., & Ismail, A. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03035-14 · Cited by 54 · see citing works

Successful Treatment of Fluconazole-Resistant Oropharyngeal Candidiasis by a Combination of Fluconazole and Terbinafine

Ghannoum, M. A., & Elewski, B. E. (1999) · Clinical and Diagnostic Laboratory Immunology · doi:10.1128/cdli.6.6.921-923.1999 · Cited by 54 · see citing works

Ion-channel blocker sensitivity of voltage-gated calcium-channel homologue Cch1 in Saccharomyces cerevisiae

Teng, J., Goto, R., Iida, K., Kojima, I., & Iida, H. (2008) · Microbiology · doi:10.1099/mic.0.2008/021089-0 · Cited by 53 · see citing works

Azole resistance in Candida auris: mechanisms and combinatorial therapy

Jangir, P., Kalra, S., Tanwar, S., & Bari, V. K. (2023) · Apmis · doi:10.1111/apm.13336 · Cited by 53 · see citing works

Membrane raft lipid constituents affect drug susceptibilities of Candida albicans

Prasad, T., Pasrija, R., & Prasad, R. (2005) · Biochemical Society Transactions · doi:10.1042/bst20051219 · Cited by 51 · see citing works

Identification and Functional Characterization of Rca1, a Transcription Factor Involved in both Antifungal Susceptibility and Host Response in Candida albicans

Vandeputte, P., Pradervand, S., Ischer, F., Coste, A. T., Ferrari, S., Harshman, K., & Sanglard, D. (2012) · Eukaryotic Cell · doi:10.1128/ec.00134-12 · Cited by 51 · see citing works

Repurposing antipsychotic drugs into antifungal agents: Synergistic combinations of azoles and bromperidol derivatives in the treatment of various fungal infections

Holbrook, S. Y. L., Garzan, A., Dennis, E. K., Shrestha, S. K., & Garneau-Tsodikova, S. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.07.030 · Cited by 51 · see citing works

Drug Repurposing of Haloperidol: Discovery of New Benzocyclane Derivatives as Potent Antifungal Agents against Cryptococcosis and Candidiasis

Ji, C., Liu, N., Tu, J., Li, Z., Han, G., Li, J., & Sheng, C. (2019) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.9b00197 · Cited by 51 · see citing works

The Right Tool for the Job: An Overview of Hsp90 Inhibitors

Koren, J., & Blagg, B. S. J. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-40204-4_9 · Cited by 51 · see citing works

Impact of tolerance to fluconazole on treatment response in <i>Candida albicans</i> bloodstream infection

Levinson, T., Dahan, A., Novikov, A., Paran, Y., Berman, J., & Ben‐Ami, R. (2021) · Mycoses · doi:10.1111/myc.13191 · Cited by 50 · see citing works

Global proteomic analyses define an environmentally contingent Hsp90 interactome and reveal chaperone-dependent regulation of stress granule proteins and the R2TP complex in a fungal pathogen

O’Meara, T. R., O’Meara, M. J., Polvi, E. J., Pourhaghighi, M. R., Liston, S. D., Lin, Z.-Y., Veri, A. O., Emili, A., Gingras, A.-C., & Cowen, L. E. (2019) · PLoS Biology · doi:10.1371/journal.pbio.3000358 · Cited by 49 · see citing works

Calcium-calcineurin signaling pathway in Candida albicans: A potential drug target

Li, W., Shrivastava, M., Lu, H., & Jiang, Y. (2021) · Microbiological Research · doi:10.1016/j.micres.2021.126786 · Cited by 47 · see citing works

Synergism of Voriconazole and Terbinafine against Candida albicans Isolates from Human Immunodeficiency Virus-Infected Patients with Oropharyngeal Candidiasis

Weig, M., & Müller, F. C. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.3.966-968.2001 · Cited by 46 · see citing works

Hexokinase and Glucokinases Are Essential for Fitness and Virulence in the Pathogenic Yeast Candida albicans

Laurian, R., Dementhon, K., Doumèche, B., Soulard, A., Noël, T., Lemaire, M., & Cotton, P. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00327 · Cited by 46 · see citing works

RTA2 is involved in calcineurin-mediated azole resistance and sphingoid long-chain base release in Candida albicans

Jia, X. M., Wang, Y., Jia, Y., Gao, P. H., Xu, Y. G., Wang, L., Cao, Y. Y., Cao, Y. B., Zhang, L. X., & Jiang, Y. Y. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8409-3 · Cited by 45 · see citing works

Baicalein: Promising Therapeutic Applications With Special Reference to Published Patents

Gupta, S., Buttar, H. S., Kaur, G., & Tuli, H. S. (2022) · Pharmaceutical Patent Analyst · doi:10.4155/ppa-2021-0027 · Cited by 45 · see citing works

Posaconazole: A new oral antifungal agent with an expanded spectrum of activity

Morris, M. I. (2009) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp070532 · Cited by 44 · see citing works

Inhibitory effect of verapamil onCandida albicanshyphal development, adhesion and gastrointestinal colonization

Yu, Q., Ding, X., Zhang, B., Xu, N., Jia, C., Mao, J., Zhang, B., Xing, L., & Li, M. (2014) · FEMS Yeast Research · doi:10.1111/1567-1364.12150 · Cited by 44 · see citing works

Small Molecule Inhibitors of the Candida albicans Budded-to-Hyphal Transition Act through Multiple Signaling Pathways

Midkiff, J., Borochoff-Porte, N., White, D., & Johnson, D. I. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025395 · Cited by 44 · see citing works

In Vitro Effects of Plantago Major Extract, Aucubin, and Baicalein on Candida albicans Biofilm Formation, Metabolic Activity, and Cell Surface Hydrophobicity

Shirley, K. P., Windsor, L. J., Eckert, G. J., & Gregory, R. L. (2015) · Journal of Prosthodontics · doi:10.1111/jopr.12411 · Cited by 42 · see citing works

The protein kinase Ire1 impacts pathogenicity of <scp> <i>Candida albicans</i> </scp> by regulating homeostatic adaptation to endoplasmic reticulum stress

Sircaik, S., Román, E., Bapat, P., Lee, K. K., Andes, D. R., Gow, N. A. R., Nobile, C. J., Pla, J., & Panwar, S. L. (2021) · Cellular Microbiology · doi:10.1111/cmi.13307 · Cited by 41 · see citing works

Evolutionary divergence in the fungal response to fluconazole revealed by soft clustering

Kuo, D., Tan, K., Zinman, G., Ravasi, T., Bar‐Joseph, Z., & Ideker, T. E. (2010) · Genome biology · doi:10.1186/gb-2010-11-7-r77 · Cited by 40 · see citing works

Baicalein Acts against Candida albicans by Targeting Eno1 and Inhibiting Glycolysis

Li, L., Lu, H., Zhang, X., Whiteway, M. S., Wu, H., Tan, S.-L., Zang, J., Tian, S., Zhen, C., Meng, X., et al. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.02085-22 · Cited by 40 · see citing works

Understanding fluconazole tolerance in Candida albicans: implications for effective treatment of candidiasis and combating invasive fungal infections

Feng, Y., Lu, H., Whiteway, M., & Jiang, Y. (2023) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2023.10.019 · Cited by 40 · see citing works

Assessment of mixture toxicity of (tri)azoles and their hepatotoxic effects in vitro by means of omics technologies

Seeger, B., Mentz, A., Knebel, C., Schmidt, F., Bednarz, H., Niehaus, K., Albaum, S., Kalinowski, J., Noll, T., Steinberg, P., et al. (2019) · Archives of Toxicology · doi:10.1007/s00204-019-02502-w · Cited by 39 · see citing works

Sphingolipids: Regulators of azole drug resistance and fungal pathogenicity

Song, J., Xiao, L., & Li, R. (2020) · Molecular Microbiology · doi:10.1111/mmi.14586 · Cited by 38 · see citing works

Amorolfine and itraconazole combination for severe toenail onychomycosis; results of an open randomized trial in Spain

Lecha, M. (2001) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2001.145s60021.x · Cited by 38 · see citing works

Post-Translational Regulation of HMG CoA ReductasePreprint

Jo, Y., & DeBose‐Boyd, R. A. (2022) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a041253 · Cited by 38 · see citing works

Combination of amorolfine with various antifungal drugs in dermatophytosis

Polak, A. (1993) · Mycoses · doi:10.1111/j.1439-0507.1993.tb00686.x · Cited by 37 · see citing works

In Vitro Synergistic Interactions of Isavuconazole and Echinocandins against Candida auris

Caballero, U., Kim, S., Eraso, E., Quindós, G., Vozmediano, V., Schmidt, S., & Jauregizar, N. (2021) · Antibiotics · doi:10.3390/antibiotics10040355 · Cited by 37 · see citing works

Antifungals in Clinical Use and the Pipeline

Johnson, M. D. (2021) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2021.03.005 · Cited by 35 · see citing works

Proton pump inhibitors act synergistically with fluconazole against resistant Candida albicans

Lü, M., Yan, H., Yu, C., Yuan, L., & Sun, S. (2020) · Scientific Reports · doi:10.1038/s41598-019-57174-4 · Cited by 34 · see citing works

Possible mechanisms of the antifungal activity of fluconazole in combination with terbinafine againstCandida albicans

Khodavandi, A., Alizadeh, F., Vanda, N. A., Karimi, G., & Chong, P. P. (2014) · Pharmaceutical Biology · doi:10.3109/13880209.2014.900808 · Cited by 33 · see citing works

Hotspot mutations and genomic expansion of ERG11 are major mechanisms of azole resistance in environmental and human commensal isolates of Candida tropicalis

Hu, T., Wang, S., Bing, J., Zheng, Q., Du, H., Li, C., Guan, Z., Bai, F., Nobile, C. J., Chu, H., et al. (2023) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2023.107010 · Cited by 33 · see citing works

Sugar Phosphorylation Controls Carbon Source Utilization and Virulence of Candida albicans

Wijnants, S., Riedelberger, M., Penninger, P., Kuchler, K., & Dijck, P. V. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01274 · Cited by 32 · see citing works

Synergistic antifungal effects of curcumin derivatives as fungal biofilm inhibitors with fluconazole

Dong, H., Wang, Y., Peng, X., Zhou, H., Zhao, F., Jiang, Y., Zhang, D., & Jin, Y. (2021) · Chemical Biology & Drug Design · doi:10.1111/cbdd.13827 · Cited by 32 · see citing works

Chemogenomic Profiling of the Fungal Pathogen Candida albicans

Chen, Y., Mallick, J., Maqnas, A., Sun, Y., Choudhury, B. I., Côte, P., Yan, L., Ni, T., Li, Y., Zhang, D., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02365-17 · Cited by 30 · see citing works

In vitro and in vivo interaction of caspofungin with isavuconazole against Candida auris planktonic cells and biofilms

Nagy, F., Tóth, Z., Nyikos, F., Forgács, L., Jakab, Á., Borman, A. M., Majoros, L., & Kovács, R. (2021) · Medical Mycology · doi:10.1093/mmy/myab032 · Cited by 30 · see citing works

Effects of Hsp90 Inhibitor Ganetespib on Inhibition of Azole-Resistant Candida albicans

Yuan, R., Tu, J., Sheng, C., Chen, X., & Liu, N. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.680382 · Cited by 30 · see citing works

Human Fungal Infection, Immune Response, and Clinical Challenge—a Perspective During COVID-19 Pandemic

Naveen, K. V., Saravanakumar, K., Sathiyaseelan, A., MubarakAli, D., & Wang, M. (2022) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-022-03979-5 · Cited by 30 · see citing works

A Small Molecule Inhibitor of Erg251 Makes Fluconazole Fungicidal by Inhibiting the Synthesis of the 14α-Methylsterols

Lu, H., Li, W., Whiteway, M., Wang, H., Zhu, S., Ji, Z., Feng, Y., Yan, L., Fang, T., Li, L., et al. (2023) · mBio · doi:10.1128/mbio.02639-22 · Cited by 30 · see citing works

Myriocin enhances the antifungal activity of fluconazole by blocking the membrane localization of the efflux pump Cdr1

Wang, H., Ji, Z., Feng, Y., Yan, T., Cao, Y., Lu, H., & Jiang, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1101553 · Cited by 30 · see citing works

Chaperone Networks in Fungal Pathogens of Humans

Horianopoulos, L. C., & Kronstad, J. W. (2021) · Journal of Fungi · doi:10.3390/jof7030209 · Cited by 29 · see citing works

In vitro and in vivo Efficacy of a Synergistic Combination of Itraconazole and Verapamil Against Aspergillus fumigatus

Zeng, Q., Zhang, Z., Chen, P., Long, N., Lü, L., & Sang, H. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01266 · Cited by 28 · see citing works

Unexpected Inhibitory Effect of Octenidine Dihydrochloride on Candida albicans Filamentation by Impairing Ergosterol Biosynthesis and Disrupting Cell Membrane Integrity

Fang, T., Xiong, J., Wang, L., Feng, Z. C., Hang, S., Yu, J., Li, W., Feng, Y., Lu, H., & Jiang, Y. (2023) · Antibiotics · doi:10.3390/antibiotics12121675 · Cited by 28 · see citing works

Evaluation of baicalein, chitosan and usnic acid effect on Candida parapsilosis and Candida krusei biofilm using a Cellavista device

Kvasničková, E., Maťátková, O., Čejková, A., & Masák, J. (2015) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2015.09.002 · Cited by 27 · see citing works

Letrozole, berberine, or their combination for anovulatory infertility in women with polycystic ovary syndrome: study design of a double-blind randomised controlled trial

Li, Y., Kuang, H., Shen, W., Ma, H., Zhang, Y., Stener‐Victorin, E., Hung, E., Ng, E. H. Y., Liu, J., Kuang, H., et al. (2013) · BMJ Open · doi:10.1136/bmjopen-2013-003934 · Cited by 26 · see citing works

Production of Trichophyton rubrum microspores in large quantities and its application to evaluate amorolfine/azole compound interactions in vitro

Laurent, A. E., & Monod, M. (2017) · Mycoses · doi:10.1111/myc.12632 · Cited by 25 · see citing works

The Role of HSP90 in Preserving the Integrity of Genomes Against Transposons Is Evolutionarily Conserved

Specchia, V., & Bozzetti, M. P. (2021) · Cells · doi:10.3390/cells10051096 · Cited by 25 · see citing works

In Vitro Antifungal Combination of Terbinafine with Itraconazole against Isolates of Trichophyton Species

Bidaud, A.-L., Schwarz, P., Chowdhary, A., & Dannaoui, É. (2021) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01449-21 · Cited by 23 · see citing works

The efflux pump inhibitor tetrandrine exhibits synergism with fluconazole or voriconazole against Candida parapsilosis

Zhao, Y., Liu, W., Shen, Y., Li, D., Zhu, K., & Zhang, H. (2019) · Molecular Biology Reports · doi:10.1007/s11033-019-05020-1 · Cited by 22 · see citing works

Identification of an Exceptionally Long Intron in the HAC1 Gene of Candida parapsilosis

Iracane, E., Donovan, P. D., Ola, M., Butler, G., & Holland, L. (2018) · mSphere · doi:10.1128/msphere.00532-18 · Cited by 21 · see citing works

The Antifungal and Synergistic Effect of Bisphosphonates in Cryptococcus

Kane, A., Campbell, L. T., Ky, D., Hibbs, D. E., & Carter, D. A. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01753-20 · Cited by 21 · see citing works

Cis-2-dodecenoic Acid Mediates Its Synergistic Effect with Triazoles by Interfering with Efflux Pumps in Fluconazole-resistant Candida albicans.

Yang, D., Hu, Y. L., Yin, Z. X., Zeng, G., Li, D., Zhang, Y. Q., Xu, Z., Guan, X. M., Weng, L. X., & Wang, L. H. (2019) · PubMed · doi:10.3967/bes2019.027 · Cited by 20 · see citing works

Can repurposing of existing drugs provide more effective therapies for invasive fungal infections?

Katragkou, A., Roilides, E., & Walsh, T. J. (2016) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2016.1186647 · Cited by 19 · see citing works

Monoamine oxidase A: An emerging therapeutic target in prostate cancer

Chen, C., & Wu, B. J. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1137050 · Cited by 18 · see citing works

Sertraline Has Fungicidal Activity Against Candida Spp. and Acts by Inhibiting Membrane and Cell Wall Biosynthesis

Rodrigues, D. S., Cabral, V. P. D. F., Barbosa, A. D., Sá, L. G. D. A. V., da Silva, C. R., Moreira, L. E. A., Neto, J. B., Silva, J., dos Santos, H. S., Marinho, E. S., et al. (2023) · Future Microbiology · doi:10.2217/fmb-2022-0254 · Cited by 18 · see citing works

Calcineurin-mediated intracellular organelle calcium homeostasis is required for the survival of fungal pathogens upon extracellular calcium stimuli

Zhang, C., Ren, Y., Gu, H., Gao, L., Zhang, Y., & Lü, L. (2021) · Virulence · doi:10.1080/21505594.2021.1909954 · Cited by 17 · see citing works

Tetrandrine enhances the antifungal activity of fluconazole in a murine model of disseminated candidiasis

Jianping, S., Li, S., Gao, A., Zhu, K., & Zhang, H. (2018) · Phytomedicine · doi:10.1016/j.phymed.2018.06.003 · Cited by 16 · see citing works

Isobavachalcone Exhibits Potent Antifungal Efficacy by Inhibiting Enolase Activity and Glycolysis in Candida albicans.

Wu, H., Ji, Z., Huang, X., Li, L.-P., Hang, S.-J., Yu, J., Lu, H., & Jiang, Y.-Y. (2024) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.4c00399 · Cited by 16 · see citing works

Otilonium Bromide Exhibits Potent Antifungal Effects by Blocking Ergosterol Plasma Membrane Localization and Triggering Cytotoxic Autophagy in <i>Candida Albicans</i>

Zhen, C., Wang, L., Feng, Y., Whiteway, M., Hang, S., Yu, J., Lu, H., & Jiang, Y. (2024) · Advanced Science · doi:10.1002/advs.202406473 · Cited by 16 · see citing works

Synergistic Effects of Tetrandrine with Posaconazole Against Aspergillus fumigatus

Li, S., Song, Y., Jiang, L., Zhao, Y., Guo, H., Li, D., Zhu, K., & Zhang, H. (2017) · Microbial Drug Resistance · doi:10.1089/mdr.2016.0217 · Cited by 14 · see citing works

Halofantrine Hydrochloride Acts as an Antioxidant Ability Inhibitor That Enhances Oxidative Stress Damage to Candida albicans

Xiong, J., Wang, L., Feng, Z., Hang, S., Yu, J., Feng, Y., Lu, H., & Jiang, Y. (2024) · Antioxidants · doi:10.3390/antiox13020223 · Cited by 14 · see citing works

Geldanamycin confers fungicidal properties to azole by triggering the activation of succinate dehydrogenase

Xiong, J., Wang, L., Feng, Y., Zhen, C., Hang, S., Yu, J., Lu, H., & Jiang, Y. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122699 · Cited by 14 · see citing works

Pitavastatin Calcium Confers Fungicidal Properties to Fluconazole by Inhibiting Ubiquinone Biosynthesis and Generating Reactive Oxygen Species

Li, W., Feng, Y., Feng, Z., Wang, L., Whiteway, M., Lu, H., & Jiang, Y. (2024) · Antioxidants · doi:10.3390/antiox13060667 · Cited by 14 · see citing works

Repurposing the FDA‐approved anticancer agent ponatinib as a fluconazole potentiator by suppression of multidrug efflux and Pma1 expression in a broad spectrum of yeast species

Liu, L. L., Jiang, T., Zhou, J., Mei, Y., Li, J., Tan, J.-C., Wei, L., Li, J., Peng, Y., Chen, C., et al. (2021) · Microbial Biotechnology · doi:10.1111/1751-7915.13814 · Cited by 12 · see citing works

Design, synthesis, and SAR study of 3-(benzo[d][1,3]dioxol-5-yl)-N-benzylpropanamide as novel potent synergists against fluconazole-resistant Candida albicans

Cai, Z. J., Ding, Z., Hao, Y., Ni, T., Xie, F., Zhao, J., Li, R., Yu, S., Wang, T., Chai, X., et al. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.08.053 · Cited by 10 · see citing works

Candida glabrata complex from patients with healthcare-associated infections in Mansoura University Hospitals, Egypt: distribution, antifungal susceptibility and effect of fluconazole and polymyxin B combination

Mashaly, G. E.-S., & Shrief, R. (2019) · GERMS · doi:10.18683/germs.2019.1167 · Cited by 10 · see citing works

Downregulation of Squalene Synthase Broadly Impacts Isoprenoid Biosynthesis in Guayule

Placido, D. F., Dong, N., Amer, B., Dong, C., Ponciano, G., Kahlon, T. S., Whalen, M. C., Baidoo, E. E. K., & McMahan, C. M. (2022) · Metabolites · doi:10.3390/metabo12040303 · Cited by 9 · see citing works

Known Antimicrobials Versus Nortriptyline in Candida albicans: Repositioning an Old Drug for New Targets

Caldara, M., & Marmiroli, N. (2020) · Microorganisms · doi:10.3390/microorganisms8050742 · Cited by 8 · see citing works

Aequorin as a Useful Calcium-Sensing Reporter in Candida albicans

Sanglard, D. (2021) · Journal of Fungi · doi:10.3390/jof7040319 · Cited by 6 · see citing works

Integrating ensemble machine learning and multi-omics approaches to identify Dp44mT as a novel anti-Candida albicans agent targeting cellular iron homeostasis

Chai, X., Jiang, Y., Lu, H. J., & Huang, X. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1574990 · Cited by 8 · see citing works

Candida albicans: a historical overview of investigations into an important human pathogen

Shrivastava, M., & Whiteway, M. S. (2025) · Canadian Journal of Microbiology · doi:10.1139/cjm-2025-0036 · Cited by 7 · see citing works

Amiodarone and Ravuconazole Combination Potentiates Chemotherapy against Drug-Resistant Trypanosoma cruzi Strains

Raimundo, B. V. B., Mazzeti, A. L., Bahia, M. T., Caldas, I. S., Fernandes, V. Â., dos Santos, E. G., Aguiar‐Soares, R. D. D. O., de Miranda, A. S., Novaes, R. D., & Diniz, L. D. F. (2025) · ACS Omega · doi:10.1021/acsomega.5c00996 · Cited by 3 · see citing works

Galactose Inhibits the Translation of Erg1 that Enhances the Antifungal Activities of Azoles Against Candida albicans

Hang, S., Wang, L., Ji, Z., Shen, X., Fang, X., Li, W., Jiang, Y., & Lu, H. (2025) · Antibiotics · doi:10.3390/antibiotics14080799 · Cited by 4 · see citing works

Innovative green niosomal piperlongumine as a novel topical treatment for dermatophytosis in guinea pigs model

Haghani, I., Raeisabadi, A., Akhtari, J., Arbabi, A., Abastabar, M., Hedayati, M. T., Yahyazadeh, Z., Amiri, F. T., Hashemi, S. M. H., Davoodi, L., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-21729-5 · Cited by 3 · see citing works

In vitro and in vivo synergistic antifungal effects of microbially synthesized silver and magnetic iron oxide nanoparticles against Candida albicans

Bahmaee, F., Khodavandi, P., Khodavandi, A., & Alizadeh, F. (2025) · Inorganic Chemistry Communications · doi:10.1016/j.inoche.2025.115093 · Cited by 2 · see citing works

Molecular frontiers of fungal autophagy: from molecular mechanisms to potential targets for antifungal drug discovery

Cao, J., Shang, X., Yang, Q., & Ju, J. (2026) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-026-04947-5 · Cited by 2 · see citing works

Fungal Antimicrobial Resistance: Mechanisms, Drivers, and Global Clinical Burden

Baral, B. (2026) · ChemFoodChem · doi:10.1002/cfch.70026 · Cited by 2 · see citing works

Disruption of the UPC2 Gene Enhances Fluconazole Antifungal Activity by Inhibiting HAC1 mRNA Splicing in Candida albicans

Yu, J., Jiang, B., Xiong, J., Xu, X., Xu, L., Jiang, Y., & Lu, H. (2026) · Pathogens · doi:10.3390/pathogens15060629 · Cited by 2 · see citing works

Advancing the Understanding of the Mo-CBP2 Protein: Unraveling Its Antifungal and Antibiofilm Properties Against Candida Species

Neto, J. X. D. S., Leite, L. O., da Silva, A. P. A., Guedes, M. I. F., & Sousa, D. O. B. (2025) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-025-10744-7 · Cited by 1 · see citing works

Kaempferol: advances in biosynthesis, molecular mechanisms, and therapeutic applications

Zaki, E. S., Sabry, M. O., Abou-Elazm, F. I., El‐Dessouki, A. M., Khalaf, S. S., Ramadan, A., El‐Shiekh, R. A., & Aboutaleb, A. S. (2026) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-026-05364-z · Cited by 2 · see citing works

Recombinant subunit vaccines against invasive fungal infections: mechanisms, development progress, and therapeutic potential

Xu, X., Jiang, B., Xiong, J., Jiang, Y., & Lu, H. (2026) · Vaccine · doi:10.1016/j.vaccine.2026.128864 · Cited by 1 · see citing works

Synthesis and Antifungal Evaluation Against Candida spp. of 5-Arylfuran-2-Carboxamide Derivatives

Mirabile, S., Ginestra, G., Pennisi, R., Barreca, D., Mandalari, G., & Gitto, R. (2025) · Microorganisms · doi:10.3390/microorganisms13081835

Body temperature drives azole tolerance in Candida albicans by hindering the autophagic degradation of Erg11Preprint

Feng, Y., Zhen, C., Li, W., Whiteway, M. S., Fang, X., Shen, X., Jiang, Y., & Lu, H. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.15.676225

Antagonism Rather Than Synergy: Ibuprofen-Antifungal Interactions Depend on Strain Genetics and Nutrient EnvironmentPreprint

Prabakaran, A., & Sinha, H. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.22.701080

Multifaceted antifungal and antibiofilm activities of Mo-CBP2 against Candida species: Structural disruption, cell membrane, cell wall interaction, and synergistic potential

Neto, J. X. D. S., da Silva, A. P. A., Guedes, M. I. F., & Sousa, D. O. B. (2026) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2026.151760

RGD-Functionalized ZIF-8 Nanocarriers Enable Highly Selective Delivery of Repurposed Gliclazide in Breast Cancer

Silvaraju, G., Borzehandani, M. Y., Johari, N. A. S., Saad, N., Razali, R., Shaarani, S. H. N., & Kamal, N. A. M. A. (2026) · ACS Applied Bio Materials · doi:10.1021/acsabm.6c00092

Body temperature drives azole tolerance in Candida albicans by hindering the autophagic degradation of Erg11

Feng, Y., Zhen, C., Li, W., Whiteway, M. S., Fang, X., Shen, X., Jiang, Y., & Lu, H. (2026) · Microbiological Research · doi:10.1016/j.micres.2026.128595 · Cited by 2 · see citing works

Unveiling acetamide coupled benzothiazole hydrazones as potential anti-proliferative agents: an experimental and computational approach

Imtiaz, M. S., Persoons, L., Daelemans, D., Jonghe, S. D., & Hameed, S. (2026) · RSC Advances · doi:10.1039/d6ra03835b

Pramocaine hydrochloride potentiates fluconazole against Candida albicans biofilms by targeting Erg12 and inhibiting ubiquinone biosynthesis

Hang, S., Jiang, B., Li, W., Xu, X., Xu, L., Xiong, J., Jiang, Y., & Lu, H. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.118302 · Cited by 1 · see citing works

Augmenting Azoles with Drug Synergy to Expand the Antifungal Toolbox

Kane, A., & Carter, D. A. (2022) · Pharmaceuticals · doi:10.3390/ph15040482 · Cited by 55 · see citing works

Azole potentiation in Candida species

Stenkiewicz-Witeska, J., & Ene, I. V. (2023) · PLoS Pathogens · doi:10.1371/journal.ppat.1011583 · Cited by 20 · see citing works

Azole Antifungals Under Pressure: Therapeutic Challenges and Multifaceted Resistance Mechanisms

dos Santos, A. L. S., Ramos, L. S., de Mello, T. P., Viganor, L., Nonato, N. M. B. D. M., Pinheiro, R. E. E., & Branquinha, M. H. (2025) · Current Medicinal Chemistry · doi:10.2174/0109298673413219250826055238

Research advance of fungal resistance mechanism against azoles

Zhou, B. (2012) · World Clinical Drugs

Medically Important Fungi Respond to Azole Drugs: An Update

Zavřel, M., & White, T. C. (2015) · Future Microbiology · doi:10.2217/fmb.15.47 · Cited by 64 · see citing works